ANTI-MIF IMMUNHISTOCHEMIE

European patent · EP2872897 · Deleted

Register entry

Publication number
EP2872897
Application number
EP13734784
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 9, 2013
Published
May 20, 2015
Granted
Oct 18, 2017
Deleted
Feb 24, 2026
Reason
Annual fee unpaid
IPC classes
G01N 33/68 (2006.01)
Priority
US 201261669964 P 10.07.2012
US 201261719793 P 29.10.2012
US 201361778117 P 12.03.2013
PCT application
PCT/EP2013/064461 09.07.2013
PCT publication
WO2014/009355 16.01.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 24, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.02.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.02.2026

  2. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  3. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  4. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  5. Sep 23, 2021

    Transferred

    Owner
    Baxalta GmbH, Thurgauerstrasse 130, 8152 Glattpark, Opfikon, Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn, IL 60015, USA → Baxalta GmbH, Zählerweg 4, 6300 Zug, Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn, IL 60015, USA

    Published in Swissreg on 23.09.2021

  6. Oct 18, 2017

    Granted

    Published in Swissreg on 18.10.2017

Parties

Inventor

THIELE, Michael

A-1030 Wien, AT

KERSCHBAUMER, Randolf

A-3400 Klosterneuburg, AT

VOELKEL, Dirk

A-1220 Wien, AT

DOUILLARD, Patrice

A-1020 Wien, AT

SCHEIFLINGER, Friedrich

A-1090 Wien, AT

SCHINAGL, Alexander

A-1200 Wien, AT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.